MENLO PARK, Calif.--GeneTrace announced it will collaborate with Monsanto on plant and animal genomics research. Monsanto will make a $17.2 million investment in GeneTrace, a genetic information provider based here. Monsanto will get exclusive options to license all aspects of GeneTrace's genomics technologies for plant and animal agriculture worldwide, research and development funding, equipment purchases, supply agreements, and an equity investment. As part of the initial agreement, Monsanto has exercised an option to license GeneTrace's genotyping methods and intends to use the technology for many crops, including corn and soybeans.
GeneTrace also announced that it has appointed George LaMotte to the position of CEO. LaMotte, who holds a PhD in molecular immunology from Cornell and was a fellow in molecular immunology at Scripps Clinic and Research Foundation, most recently served with the healthcare business consultants Owen & Associates.